Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
T Gomez-Isla; H L West; G W Rebeck; S D Harr; J H Growdon; J J Locascio; T T Perls; L A Lipsitz; B T Hyman (Profiled Authors: Hyman, Bradley T; Growdon, John H)
Neurology Service, Massachusetts General Hospital, Boston, MA 02114, USA.
Annals of neurology 1996;39(1):62-70.
Inheritance of the apolipoprotein E (apoE) epsilon 4 allele is associated with a high likelihood of developing Alzheimer's disease (AD). The pathophysiologic basis of this genetic influence is unknown. We reasoned that understanding the influence of apoE epsilon 4 on the clinical course and neuropathological features of AD may provide tests of potential mechanisms. We carried out a prospective longitudinal study to compare the age of onset, duration, and rate of progression of 359 AD patients to apoE genotype. Thirty-one of the individuals who died during the study were available for quantitative neuropathological evaluation. Statistically unbiased stereological counts of neurofibrillary tangles (NFTs) and A beta deposits were assessed in a high-order association cortex, the superior temporal sulcus. Analysis of clinical parameters compared with apoE genotype showed that the epsilon 4 allele is associated with an earlier age of onset but no change in rate of progression of dementia. Quantitative neuropathological assessment revealed that NFTs were strongly associated with clinical measures of dementia duration and severity but not with apoE genotype. A beta deposition, by contrast, was not related to clinical features but was elevated in association with apoE epsilon 4. These results indicate that apoE epsilon 4 is associated with selective clinical and neuropathological features of AD and support hypotheses that focus on an influence of apoE epsilon 4 on amyloid deposition.
6 Originating Grant
-
1.
HYMAN, BRADLEY T
Massachusetts Alzheimer's Disease Research Center
1 April 1997 - 31 March 2014
NATIONAL INSTITUTE ON AGING
Total Funding: $ 13,238,070
-
2.
Growdon, John H
Massachusetts Alzheimer's Disease Research Center
1 April 1997 - 31 March 2009
NATIONAL INSTITUTE ON AGING
Total Funding: $ 36,612,653
-
3.
Hyman, Bradley T
1 September 1994 - 31 January 2010
NATIONAL INSTITUTE ON AGING
Total Funding: $ 4,716,276
-
4.
HYMAN, BRADLEY T
PATHOLOGICAL ALTERATIONS IN ALZHEIMER'S DISEASE
1 August 1989 - 30 November 1994
NATIONAL INSTITUTE ON AGING
Total Funding: $ 554,426
-
5.
HYMAN, BRADLEY T
Neurologic Alterations in Alzheimer's Disease
1 August 1989 - 31 August 2011
NATIONAL INSTITUTE ON AGING
Total Funding: $ 7,608,351
-
6.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Grants
-
1.
Mayeux, Richard
Epidemiology of Dementia In An Urban Community
1 February 1989 - 30 June 2009
NATIONAL INSTITUTE ON AGING
Total Funding: $ 40,531,208
-
2.
COLE, GREGORY M
Preclinical Pharmacogenomics and Synaptic Biomarkers for Alzheimer's Disease
1 September 2011 - 31 March 2016
NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE
Total Funding: $ 1,109,185
-
3.
HYMAN, BRADLEY T
A Model of Early Alzheimer Disease
1 April 2011 - 31 March 2013
NATIONAL INSTITUTE ON AGING
Total Funding: $ 392,821
Related Publications
-
1.
1997Y Stern; J Brandt; M Albert; D M Jacobs; X Liu; K Bell; K Marder; M Sano; S Albert; C Del-Castillo Castenada; et al.
Annals of neurology 1997;41(5):615-20. -
2.
1999R Barber; A Gholkar; P Scheltens; C Ballard; I G McKeith; C M Morris; J T O'Brien
Archives of neurology 1999;56(8):961-5. -
3.
1996M Lehtovirta; H Soininen; M P Laakso; K Partanen; S Helisalmi; A Mannermaa; M Ryynänen; J Kuikka; P Hartikainen; P J Riekkinen
SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.
Journal of neurology, neurosurgery, and psychiatry 1996;60(6):644-9.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
505









-
149









-
438









-
321









-
219









-
571










